Released Aug 14, 2012, after the close
10-Q filed Aug 14, 2012, 45 days after period end · 0001193125-12-355531
Q2 2012 · 10-Q
Revenue$3.38M$3.38M no prior Q2 2011 on file+23.0% vs Q1 2012
Net Income-$15.66M-$15.66M N/M vs Q2 2011N/M vs Q1 2012
EPS Diluted-$0.03-$0.03 N/M vs Q2 2011N/M vs Q1 2012
Gross Profit$2,914,000—
Operating Cash Flowderived-$6,745,000N/M
Margins · derived
Gross margin86.2%
Net margin-463.0%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|
| Revenue | $3.38M | — | — |
| Net Income | -$15.66M | -$3.75M | -$2.14M |
| EPS Diluted | -$0.03 | -$0.10 | -$0.12 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
SELLAS Life Sciences Group, Inc. · CIK 1390478 · Engraved from SEC EDGAR